Location History:
- Ibaraki, JP (2007 - 2020)
- Tokyo, JP (2021)
Company Filing History:
2 out of 9 
1 out of 31 
1 out of 2 
Years Active: 2007-2021
Title: Innovations of Tsugumine Shu in Vaccine Development
Introduction
Tsugumine Shu is a notable inventor based in Ibaraki, Japan, recognized for his contributions to the field of vaccine development. He holds three patents that showcase his innovative approach to combating infectious diseases. His work focuses on creating effective vaccines using advanced methodologies.
Latest Patents
One of his latest patents is for an infectious disease vaccine using a non-infectious paramyxovirus particle. In this invention, a non-infectious particle has been produced, comprising a pathogen antigen protein expressed on the surface of a virus particle missing at least one species of paramyxovirus envelope protein. This particle has been found to hold a large amount of antigen protein compared to an infectious particle and is capable of eliciting a host immune response with extremely high efficiency. The non-infectious particle is useful as a vaccine against pathogenic viruses. Another significant patent is for an anti-vaccine using a Sendai virus as a vector. This application provides a recombinant Sendai virus vector vaccine that expresses immunodominant antigens and can be used as a therapeutic and preventive vaccine against tuberculosis.
Career Highlights
Throughout his career, Tsugumine Shu has worked with various companies, including Id Pharma Co., Ltd. and Dna Vec Research Inc. His innovative work in vaccine development has positioned him as a key figure in the field, contributing to advancements that have the potential to save lives.
Collaborations
He has collaborated with notable individuals in the industry, including Kaio Kitazato and Hidekazu Kuma. These collaborations have further enhanced his research and development efforts in vaccine technology.
Conclusion
Tsugumine Shu's innovative contributions to vaccine development highlight his commitment to addressing public health challenges. His patents reflect a deep understanding of immunology and a dedication to creating effective solutions against infectious diseases.